Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Oncology Active Pharmaceutical Ingredients (APIs) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global oncology active pharmaceutical ingredients (APIs) market is expected to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Oncology APIs refer to the biologically active components present in anti-cancer drugs. The growing incidences of cancer coupled with the rising number of R&D activities pertaining to anti-cancer drugs are primarily driving the market for oncology APIs. Moreover, the increasing awareness towards the improved efficacy of various APIs on targeted cancerous cells is also propelling their demand in oncology therapeutics.

The market is further being driven by the rising investments of several biotech and pharmaceutical companies in anti-cancer drug discovery and development. The emergence of novel biomarkers with minimal effects on non-cancerous cells is also proliferating the market for oncology APIs. Besides this, the increasing consumer health concerns towards the numerous side effects of chemotherapy treatments are also augmenting the demand for biologically active drugs with lower dosages. Additionally, the market for generic oncology APIs is also exhibiting robust growth, catalysed by the rising number of patent expiries of branded blockbuster drugs. Furthermore, several technological advancements have also led to the introduction of oncology drugs with higher efficacy and minimum side effects. For instance, the increasing penetration of advanced molecular techniques, such as recombinant DNA technology is also propelling the demand for safer and target-oriented oncology drugs.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology active pharmaceutical ingredients (APIs) market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on drug type, manufacturer type, type of synthesis and indication.

Breakup by Drug Type:

  • Innovative Oncology APIs
  • Generic Oncology APIs
     

Breakup by Manufacturer Type:

  • Captive Manufacturers
  • Merchant Manufacturers
     

Breakup by Type of Synthesis

  • Synthetic Oncology APIs
  • Biotech Oncology APIs
     

Breakup by Indication:

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Liver Cancer
  • Esophagus Cancer
  • Cervical Cancer
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
    • Turkey
    • Saudi Arabia
    • Others
       

Competitive Landscape:

The report has also analysed the competitive landscape of the market along with the profiles of the key players.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Drug Type, Manufacturer Type, Type of Synthesis, Indication, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Turkey, Saudi Arabia
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global oncology API market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oncology API market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the manufacturer type?
  • What is the breakup of the market based on the type of synthesis?
  • What is the breakup of the market based on the indication?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global oncology API market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Oncology API Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Type
    6.1    Innovative Oncology APIs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Generic Oncology APIs
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Manufacturer Type
    7.1    Captive Manufacturers
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Merchant Manufacturers
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Type of Synthesis
    8.1    Synthetic Oncology APIs
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Biotech Oncology APIs
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Indication
    9.1    Lung Cancer 
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Breast Cancer 
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Colorectal Cancer
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Prostate Cancer
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Stomach Cancer
        9.5.1 Market Trends
        9.5.2 Market Forecast
    9.6    Liver Cancer
        9.6.1 Market Trends
        9.6.2 Market Forecast
    9.7    Esophagus Cancer
        9.7.1 Market Trends
        9.7.2 Market Forecast
    9.8    Cervical Cancer
        9.8.1 Market Trends
        9.8.2 Market Forecast
    9.9    Others
        9.9.1 Market Trends
        9.9.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Turkey
           10.5.1.1 Market Trends
           10.5.1.2 Market Forecast
        10.5.2 Saudi Arabia
           10.5.2.1 Market Trends
           10.5.2.2 Market Forecast
        10.5.3 Others
           10.5.3.1 Market Trends
           10.5.3.2 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players

List of Figures

Figure 1: Global: Oncology API Market: Major Drivers and Challenges
Figure 2: Global: Oncology API Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Oncology API Market: Breakup by Drug Type (in %), 2020
Figure 4: Global: Oncology API Market: Breakup by Manufacturer Type (in %), 2020
Figure 5: Global: Oncology API Market: Breakup by Type of Synthesis (in %), 2020
Figure 6: Global: Oncology API Market: Breakup by Indication (in %), 2020
Figure 7: Global: Oncology API Market: Breakup by Region (in %), 2020
Figure 8: Global: Oncology API Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 9: Global: Oncology API (Innovative) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Oncology API (Innovative) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Oncology API (Generic) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Oncology API (Generic) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Oncology API (Captive Manufacturers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Oncology API (Captive Manufacturers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Oncology API (Merchant Manufacturers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Oncology API (Merchant Manufacturers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Oncology API (Synthetic) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Oncology API (Synthetic) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Oncology API (Biotech) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Oncology API (Biotech) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Oncology API (Lung Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Oncology API (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Oncology API (Breast Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Oncology API (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Oncology API (Colorectal Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Oncology API (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Oncology API (Prostate Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Oncology API (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Oncology API (Stomach Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Oncology API (Stomach Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Oncology API (Liver Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Oncology API (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Oncology API (Esophagus Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Oncology API (Esophagus Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Oncology API (Cervical Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Oncology API (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Oncology API (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Oncology API (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: North America: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: North America: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: United States: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: United States: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Canada: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Canada: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Asia Pacific: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Asia Pacific: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: China: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: China: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Japan: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Japan: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: India: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: India: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: South Korea: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: South Korea: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Australia: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Australia: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Indonesia: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Indonesia: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Others: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Others: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Europe: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Europe: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Germany: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Germany: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: France: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: France: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: United Kingdom: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: United Kingdom: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Italy: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Italy: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Spain: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Spain: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Russia: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Russia: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Others: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Others: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Latin America: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Latin America: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Brazil: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Brazil: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Mexico: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Mexico: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Others: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Others: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Middle East and Africa: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Middle East and Africa: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Turkey: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 88: Turkey: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 89: Saudi Arabia: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 90: Saudi Arabia: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 91: Others: Oncology API Market: Sales Value (in Million US$), 2015 & 2020
Figure 92: Others: Oncology API Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 93: Global: Oncology API Industry: SWOT Analysis
Figure 94: Global: Oncology API Industry: Value Chain Analysis
Figure 95: Global: Oncology API Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Oncology API Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Oncology API Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
Table 3: Global: Oncology API Market Forecast: Breakup by Manufacturer Type (in Million US$), 2021-2026
Table 4: Global: Oncology API Market Forecast: Breakup by Type of Synthesis (in Million US$), 2021-2026
Table 5: Global: Oncology API Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 6: Global: Oncology API Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Oncology API Market: Competitive Structure
Table 8: Global: Oncology API Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Genitourinary Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Nanopore Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Asia Pacific DNA Sequencing Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Canine Atopic Dermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Europe DNA Sequencing Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Read More

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links